# " En Face " OCT's Contribution in the Detection of Macular Retinal Toxicity Signs Linked to the Chronic Treatment of Synthetic Antimalarials

> **NCT02805686** · NA · COMPLETED · sponsor: **Fondation Ophtalmologique Adolphe de Rothschild** · enrollment: 45 (actual)

## Conditions studied

- Maculopathy

## Interventions

- **DEVICE:** spectral domain optical coherence tomography
- **DEVICE:** multifocal electroretinogram

## Key facts

- **NCT ID:** NCT02805686
- **Lead sponsor:** Fondation Ophtalmologique Adolphe de Rothschild
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2018-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02805686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02805686, "" En Face " OCT's Contribution in the Detection of Macular Retinal Toxicity Signs Linked to the Chronic Treatment of Synthetic Antimalarials". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT02805686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*